Neurodegenerative disease: Mesenchymal stem cells conditioned to secrete neurotrophic factors provide hope for Huntington disease

Nature Reviews Neurology

Volumn 8, Issue 3, 2012, Pages 120-

  Malpass, Katy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; QUINOLINIC ACID;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LOSS; CELL SURVIVAL; CELL VOLUME; HUMAN; HUNTINGTIN GENE; HUNTINGTON CHOREA; MESENCHYMAL STEM CELL TRANSPLANTATION; MUTATOR GENE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; THERAPY EFFECT;

EID: 84858153975     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.22     Document Type: Article

References (1)

1. Sadan, O. et al. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease. Exp. Neurol. doi:10.1016/j.expneurol.2011.12.045